Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Pandect Bioventures, founded in 2016, is based in South San Francisco, California. The firm focuses on early-stage biotech and pharmaceutical companies, providing funding and management support from seed to Series A. They operate a 40,000 square foot incubator facility and maintain exclusive relationships with research institutions.
Pandect Bioventures invests in early-stage healthcare innovations, particularly in the biotech and pharmaceutical sectors. They assess opportunities through a rigorous process and offer customized support to help entrepreneurs reach critical business milestones.
Notable portfolio companies include Circle Pharma, which develops cell permeable macrocyclic peptides for oncology; Azkarra Therapeutics, focused on new oncology therapies based on DNA Damage Response; Valitor, a UC Berkeley spin-out modifying therapeutic proteins; Walking Fish Therapeutics, specializing in B cell medicines; and Walden Biosciences, which develops treatments for kidney disease.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.